Seeking Alpha

Sevion Therapeutics, Inc. (SVON)

From other sites
SVON vs. ETF Alternatives
Company Description
The primary business of the Company is to utilize our patented and patent-pending technology related to antibody genes, antibody discovery technology, modified cow antibodies, and antibody drug candidates, and certain genes, primarily eukaryotic translation initiation Factor 5A, or Factor 5A,... More
Sector: Healthcare
Industry: Biotechnology
Country: United States